Skip to main content
Top
Published in: BMC Infectious Diseases 1/2010

Open Access 01-12-2010 | Research article

Developing guidelines for school closure interventions to be used during a future influenza pandemic

Authors: Nilimesh Halder, Joel K Kelso, George J Milne

Published in: BMC Infectious Diseases | Issue 1/2010

Login to get access

Abstract

Background

The A/H1N1 2009 influenza pandemic revealed that operational issues of school closure interventions, such as when school closure should be initiated (activation trigger), how long schools should be closed (duration) and what type of school closure should be adopted, varied greatly between and within countries. Computer simulation can be used to examine school closure intervention strategies in order to inform public health authorities as they refine school closure guidelines in light of experience with the A/H1N1 2009 pandemic.

Methods

An individual-based simulation model was used to investigate the effectiveness of school closure interventions for influenza pandemics with R0 of 1.5, 2.0 and 2.5. The effectiveness of individual school closure and simultaneous school closure were analyzed for 2, 4 and 8 weeks closure duration, with a daily diagnosed case based intervention activation trigger scheme. The effectiveness of combining antiviral drug treatment and household prophyaxis with school closure was also investigated.

Results

Illness attack rate was reduced from 33% to 19% (14% reduction in overall attack rate) by 8 weeks school closure activating at 30 daily diagnosed cases in the community for an influenza pandemic with R0 = 1.5; when combined with antivirals a 19% (from 33% to 14%) reduction in attack rate was obtained. For R0 >= 2.0, school closure would be less effective. An 8 weeks school closure strategy gives 9% (from 50% to 41%) and 4% (from 59% to 55%) reduction in attack rate for R0 = 2.0 and 2.5 respectively; however, school closure plus antivirals would give a significant reduction (~15%) in over all attack rate. The results also suggest that an individual school closure strategy would be more effective than simultaneous school closure.

Conclusions

Our results indicate that the particular school closure strategy to be adopted depends both on the disease severity, which will determine the duration of school closure deemed acceptable, and its transmissibility. For epidemics with a low transmissibility (R0 < 2.0) and/or mild severity, individual school closures should begin once a daily community case count is exceeded. For a severe, highly transmissible epidemic (R0 >= 2.0), long duration school closure should begin as soon as possible and be combined with other interventions.
Appendix
Available only for authorised users
Literature
9.
go back to reference Cauchemez S, Ferguson NM, Wachtel C, Tegnell A, Saour G, Duncan B, Nicoll A: Closure of schools during an influenza pandemic. The Lancet Infectious Diseases. 2009, 9: 473-481. 10.1016/S1473-3099(09)70176-8.CrossRefPubMed Cauchemez S, Ferguson NM, Wachtel C, Tegnell A, Saour G, Duncan B, Nicoll A: Closure of schools during an influenza pandemic. The Lancet Infectious Diseases. 2009, 9: 473-481. 10.1016/S1473-3099(09)70176-8.CrossRefPubMed
10.
go back to reference Sypsa V, Hatzakis A: School closure is currently the main strategy to mitigate influenza A(H1N1)v: a modelling study. Euro Surveill. 2009, 14: ppi = 19240 Sypsa V, Hatzakis A: School closure is currently the main strategy to mitigate influenza A(H1N1)v: a modelling study. Euro Surveill. 2009, 14: ppi = 19240
11.
go back to reference Nishiura H, Castillo-Chavez C, Safan M, Chowell G: Transmission potential of the new influenza A (H1N1) virus and its age-specificity in Japan. Euro Surveill. 2009, 14: pii = 19227 Nishiura H, Castillo-Chavez C, Safan M, Chowell G: Transmission potential of the new influenza A (H1N1) virus and its age-specificity in Japan. Euro Surveill. 2009, 14: pii = 19227
12.
go back to reference Effler PV, Carcione D, Giele C, Dowse GK, Goggin L, Mak DB: Household responses to pandemic (H1N1) 2009 - related school closures, Perth, Western Australia. Emerg Infect Dis. 2010, 16: 205-CrossRefPubMedPubMedCentral Effler PV, Carcione D, Giele C, Dowse GK, Goggin L, Mak DB: Household responses to pandemic (H1N1) 2009 - related school closures, Perth, Western Australia. Emerg Infect Dis. 2010, 16: 205-CrossRefPubMedPubMedCentral
13.
go back to reference Nicoll A, Coulombier D: Europe's initial experience with pandemic (H1N1) 2009 - mitigation and delaying policies and practices. Euro Surveill. 2009, 14: pii = 19279 Nicoll A, Coulombier D: Europe's initial experience with pandemic (H1N1) 2009 - mitigation and delaying policies and practices. Euro Surveill. 2009, 14: pii = 19279
16.
go back to reference Longini IM, Nizam A, Xu S, Ungchusak K, Hanshaoworakul W, Cummings DAT, Halloran ME: Containing pandemic influenza at the source. Science. 2005, 309: 1083-1088. 10.1126/science.1115717.CrossRefPubMed Longini IM, Nizam A, Xu S, Ungchusak K, Hanshaoworakul W, Cummings DAT, Halloran ME: Containing pandemic influenza at the source. Science. 2005, 309: 1083-1088. 10.1126/science.1115717.CrossRefPubMed
17.
go back to reference Ferguson NM, Cummings DAT, Fraser C, Cajka JC, Cooley PC, Burke DS: Strategies for mitigating an influenza pandemic. Nature. 2006, 442: 448-452. 10.1038/nature04795.CrossRefPubMed Ferguson NM, Cummings DAT, Fraser C, Cajka JC, Cooley PC, Burke DS: Strategies for mitigating an influenza pandemic. Nature. 2006, 442: 448-452. 10.1038/nature04795.CrossRefPubMed
18.
go back to reference Germann TC, Kadau K, Longini IM, Macken CA: Mitigation strategies for pandemic influenza in the United States. PNAS. 2006, 103: 5935-5941. 10.1073/pnas.0601266103.CrossRefPubMedPubMedCentral Germann TC, Kadau K, Longini IM, Macken CA: Mitigation strategies for pandemic influenza in the United States. PNAS. 2006, 103: 5935-5941. 10.1073/pnas.0601266103.CrossRefPubMedPubMedCentral
20.
go back to reference Davey VJ, Glass RJ, Min HJ, Beyeler WE, Glass LM: Effective, robust design of community mitigation for pandemic influenza: a systematic examination of proposed US guidance. PLoS ONE. 2008, 3: e2606-10.1371/journal.pone.0002606.CrossRefPubMedPubMedCentral Davey VJ, Glass RJ, Min HJ, Beyeler WE, Glass LM: Effective, robust design of community mitigation for pandemic influenza: a systematic examination of proposed US guidance. PLoS ONE. 2008, 3: e2606-10.1371/journal.pone.0002606.CrossRefPubMedPubMedCentral
21.
go back to reference Milne GJ, Kelso JK, Kelly HA, Huband ST, McVernon J: A small community model for the transmission of infectious diseases: comparison of school closure as an intervention in individual-based models of an influenza pandemic. PLoS ONE. 2008, 3: e4005-10.1371/journal.pone.0004005.CrossRefPubMedPubMedCentral Milne GJ, Kelso JK, Kelly HA, Huband ST, McVernon J: A small community model for the transmission of infectious diseases: comparison of school closure as an intervention in individual-based models of an influenza pandemic. PLoS ONE. 2008, 3: e4005-10.1371/journal.pone.0004005.CrossRefPubMedPubMedCentral
22.
go back to reference Halloran ME, Ferguson NM, Eubank S, Longini IM, Cummings DAT, Lewis B, Xu S, Fraser C, Vullikanti A, Germann TC: Modeling targeted layered containment of an influenza pandemic in the United States. PNAS. 2008, 105: 4639-10.1073/pnas.0706849105.CrossRefPubMedPubMedCentral Halloran ME, Ferguson NM, Eubank S, Longini IM, Cummings DAT, Lewis B, Xu S, Fraser C, Vullikanti A, Germann TC: Modeling targeted layered containment of an influenza pandemic in the United States. PNAS. 2008, 105: 4639-10.1073/pnas.0706849105.CrossRefPubMedPubMedCentral
23.
go back to reference Kelso JK, Milne GJ, Kelly HA: Simulation suggests that rapid activation of social distancing can arrest epidemic development due to a novel strain of influenza. BMC Public Health. 2009, 9: 117-10.1186/1471-2458-9-117.CrossRefPubMedPubMedCentral Kelso JK, Milne GJ, Kelly HA: Simulation suggests that rapid activation of social distancing can arrest epidemic development due to a novel strain of influenza. BMC Public Health. 2009, 9: 117-10.1186/1471-2458-9-117.CrossRefPubMedPubMedCentral
24.
go back to reference Sadique M, Adams E, Edmunds W: Estimating the costs of school closure for mitigating an influenza pandemic. BMC Public Health. 2008, 8: 135-10.1186/1471-2458-8-135.CrossRefPubMedPubMedCentral Sadique M, Adams E, Edmunds W: Estimating the costs of school closure for mitigating an influenza pandemic. BMC Public Health. 2008, 8: 135-10.1186/1471-2458-8-135.CrossRefPubMedPubMedCentral
25.
go back to reference Milne G, Kelso J, Kelly H: Strategies for mitigating an influenza pandemic with pre-pandemic H5N1 vaccines. J R Soc Interface. 2010, 7: 573-586. 10.1098/rsif.2009.0312.CrossRefPubMed Milne G, Kelso J, Kelly H: Strategies for mitigating an influenza pandemic with pre-pandemic H5N1 vaccines. J R Soc Interface. 2010, 7: 573-586. 10.1098/rsif.2009.0312.CrossRefPubMed
26.
go back to reference Halder N, Kelso J, Milne G: Analysis of the effectiveness of interventions used during the 2009 H1N1 influenza pandemic. BMC Public Health. 2010, 10: 168-10.1186/1471-2458-10-168.CrossRefPubMedPubMedCentral Halder N, Kelso J, Milne G: Analysis of the effectiveness of interventions used during the 2009 H1N1 influenza pandemic. BMC Public Health. 2010, 10: 168-10.1186/1471-2458-10-168.CrossRefPubMedPubMedCentral
27.
go back to reference Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, Valleron A-J: Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol. 2008, 167: 775-785. 10.1093/aje/kwm375.CrossRefPubMed Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, Valleron A-J: Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol. 2008, 167: 775-785. 10.1093/aje/kwm375.CrossRefPubMed
28.
go back to reference Fox JP, Hall CE, Cooney MK, Foy HM: Influenzavirus infections in Seattle families, 1975-1979. Am J Epidemiol. 1982, 116: 212-227.PubMed Fox JP, Hall CE, Cooney MK, Foy HM: Influenzavirus infections in Seattle families, 1975-1979. Am J Epidemiol. 1982, 116: 212-227.PubMed
29.
go back to reference Monto A, Koopman J, Longini IMJ: Tecumseh study of illnes. XIII. Influenza infection and disease, 1976-1981. Am J Epidemiol. 1985, 121: 811-822.PubMed Monto A, Koopman J, Longini IMJ: Tecumseh study of illnes. XIII. Influenza infection and disease, 1976-1981. Am J Epidemiol. 1985, 121: 811-822.PubMed
30.
go back to reference Yang Y, Longini IM, Halloran ME: Design and evaluation of prophylactic interventions using infectious disease incidence data from close contact groups. Appl Statist. 2006, 55: 317-330. Yang Y, Longini IM, Halloran ME: Design and evaluation of prophylactic interventions using infectious disease incidence data from close contact groups. Appl Statist. 2006, 55: 317-330.
32.
go back to reference Colizza V, Barrat A, Barthelemy M, Valleron A-J, Vespignani A: Modeling the worldwide spread of pandemic influenza: baseline case and containment interventions. PLoS Medicine. 2007, 4: e16-10.1371/journal.pmed.0040013.CrossRef Colizza V, Barrat A, Barthelemy M, Valleron A-J, Vespignani A: Modeling the worldwide spread of pandemic influenza: baseline case and containment interventions. PLoS Medicine. 2007, 4: e16-10.1371/journal.pmed.0040013.CrossRef
33.
go back to reference Ciofi degli Atti ML, Merler S, Rizzo C, Ajelli M, Massari M, Manfredi P, Furlanello C, Tomba GS, Iannelli M: Mitigation measures for pandemic influenza in Italy: an individual based model considering different scenarios. PLoS ONE. 2008, 3: 1-11. 10.1371/journal.pone.0001790.CrossRef Ciofi degli Atti ML, Merler S, Rizzo C, Ajelli M, Massari M, Manfredi P, Furlanello C, Tomba GS, Iannelli M: Mitigation measures for pandemic influenza in Italy: an individual based model considering different scenarios. PLoS ONE. 2008, 3: 1-11. 10.1371/journal.pone.0001790.CrossRef
34.
go back to reference Rvachev LA, Longini IM: A mathematical model for the global spread of influenza. Math Biosci. 1985, 3-22. 10.1016/0025-5564(85)90064-1. Rvachev LA, Longini IM: A mathematical model for the global spread of influenza. Math Biosci. 1985, 3-22. 10.1016/0025-5564(85)90064-1.
35.
go back to reference Arinaminphathy N, McLean AR: Antiviral treatment for the control of pandemic influenza: some logistical constraints. J R Soc Interface. 2007, 5: 545-553. 10.1098/rsif.2007.1152.CrossRef Arinaminphathy N, McLean AR: Antiviral treatment for the control of pandemic influenza: some logistical constraints. J R Soc Interface. 2007, 5: 545-553. 10.1098/rsif.2007.1152.CrossRef
36.
go back to reference McCaw JM, McVernon J: Prophylaxis or treatment? Optimal use of an antiviral stockpile during an influenza pandemic. Math Biosci. 2007, 209: 336-360. 10.1016/j.mbs.2007.02.003.CrossRefPubMed McCaw JM, McVernon J: Prophylaxis or treatment? Optimal use of an antiviral stockpile during an influenza pandemic. Math Biosci. 2007, 209: 336-360. 10.1016/j.mbs.2007.02.003.CrossRefPubMed
37.
go back to reference Chin J, Koh G, Lee D-Y: How necessary is a fast testkit for mitigation of pandemic flu?. J R Soc Interface. 2009. Chin J, Koh G, Lee D-Y: How necessary is a fast testkit for mitigation of pandemic flu?. J R Soc Interface. 2009.
38.
go back to reference Coburn B, Wagner B, Blower S: Modeling influenza epidemics and pandemics: insights into the future of swine flu (H1N1). BMC Medicine. 2009, 7: 30-10.1186/1741-7015-7-30.CrossRefPubMedPubMedCentral Coburn B, Wagner B, Blower S: Modeling influenza epidemics and pandemics: insights into the future of swine flu (H1N1). BMC Medicine. 2009, 7: 30-10.1186/1741-7015-7-30.CrossRefPubMedPubMedCentral
39.
40.
go back to reference Arino J, Bowman CS, Moghadas SM: Antiviral resistance during pandemic influenza: implications for stockpiling and drug use. BMC Infect Dis. 2009, 9: 8-10.1186/1471-2334-9-8.CrossRefPubMedPubMedCentral Arino J, Bowman CS, Moghadas SM: Antiviral resistance during pandemic influenza: implications for stockpiling and drug use. BMC Infect Dis. 2009, 9: 8-10.1186/1471-2334-9-8.CrossRefPubMedPubMedCentral
41.
go back to reference Eichner M, Schwehm M, Duerr H, Witschi M, Koch D, Brockmann S, Vidondo B: Antiviral prophylaxis during pandemic influenza may increase drug resistance. BMC Infect Dis. 2009, 9: 4-10.1186/1471-2334-9-4.CrossRefPubMedPubMedCentral Eichner M, Schwehm M, Duerr H, Witschi M, Koch D, Brockmann S, Vidondo B: Antiviral prophylaxis during pandemic influenza may increase drug resistance. BMC Infect Dis. 2009, 9: 4-10.1186/1471-2334-9-4.CrossRefPubMedPubMedCentral
42.
go back to reference Nishiura H, Chowell G, Safan M, Castillo-Chavez C: Pros and cons of estimating the reproduction number from early epidemic growth rate of influenza A(H1N1) 2009. Theoretical Biology and Medical Modelling. 2010, 7: 10.1186/1742-4682-7-1. Nishiura H, Chowell G, Safan M, Castillo-Chavez C: Pros and cons of estimating the reproduction number from early epidemic growth rate of influenza A(H1N1) 2009. Theoretical Biology and Medical Modelling. 2010, 7: 10.1186/1742-4682-7-1.
44.
go back to reference Nishiura H, Wilson N, Baker M: Estimating the reproduction number of the novel influenza A virus (H1N1) in a Southern Hemisphere setting: preliminary estimate in New Zealand. Journal of the New Zealand Medical Association. 2009, 122: 73-77. Nishiura H, Wilson N, Baker M: Estimating the reproduction number of the novel influenza A virus (H1N1) in a Southern Hemisphere setting: preliminary estimate in New Zealand. Journal of the New Zealand Medical Association. 2009, 122: 73-77.
45.
go back to reference Fraser C, Christl DA, Cauchemez S, Hanage WP, Van Kerkhove MD, Hollingsworth TD, Griffin J, Baggaley RF, Jenkins HE, Lyons EJ, et al: Pandemic potential of a strain of influenza A (H1N1): early findings. Science. 2009, 324: 1557-1561. 10.1126/science.1176062.CrossRefPubMedPubMedCentral Fraser C, Christl DA, Cauchemez S, Hanage WP, Van Kerkhove MD, Hollingsworth TD, Griffin J, Baggaley RF, Jenkins HE, Lyons EJ, et al: Pandemic potential of a strain of influenza A (H1N1): early findings. Science. 2009, 324: 1557-1561. 10.1126/science.1176062.CrossRefPubMedPubMedCentral
46.
go back to reference McBryde E, Bergeri I, van Gemert C, Rotty J, Headley E, Simpson K, Lester R, Hellard M, Fielding J: Early transmission characteristics of influenza A (H1N1) v in Australia: Victorian state, 16 May-3 June 2009. Euro Surveill. 2009, 14: pii = 19363 McBryde E, Bergeri I, van Gemert C, Rotty J, Headley E, Simpson K, Lester R, Hellard M, Fielding J: Early transmission characteristics of influenza A (H1N1) v in Australia: Victorian state, 16 May-3 June 2009. Euro Surveill. 2009, 14: pii = 19363
47.
go back to reference Munayco C, Gomez J, Laguna-Torres V, Arrasco J, Kochel T, Fiestas V, Garcia J, Perez J, Torres I, Condori F: Epidemiological and transmissibility analysis of influenza A (H1N1) v in a southern hemisphere setting: Peru. Euro Surveill. 2009, 14: pii = 19299 Munayco C, Gomez J, Laguna-Torres V, Arrasco J, Kochel T, Fiestas V, Garcia J, Perez J, Torres I, Condori F: Epidemiological and transmissibility analysis of influenza A (H1N1) v in a southern hemisphere setting: Peru. Euro Surveill. 2009, 14: pii = 19299
Metadata
Title
Developing guidelines for school closure interventions to be used during a future influenza pandemic
Authors
Nilimesh Halder
Joel K Kelso
George J Milne
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2010
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-10-221

Other articles of this Issue 1/2010

BMC Infectious Diseases 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.